缺血性脑卒中再灌注治疗后预处理灌注谱与脑水肿的关系。
Association between pre-treatment perfusion profile and cerebral edema after reperfusion therapies in ischemic stroke.
机构信息
Department of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.
Department of Neurology, Austin Hospital, Austin Health, Heidelberg, Australia.
出版信息
J Cereb Blood Flow Metab. 2021 Nov;41(11):2887-2896. doi: 10.1177/0271678X211017696. Epub 2021 May 17.
The relationship between reperfusion and edema is unclear, with experimental and clinical data yielding conflicting results. We investigated whether the extent of salvageable and irreversibly-injured tissue at baseline influenced the effect of therapeutic reperfusion on cerebral edema. In a pooled analysis of 415 patients with anterior circulation large vessel occlusion from the Tenecteplase-versus-Alteplase-before-Endovascular-Therapy-for-Ischemic-Stroke (EXTEND-IA TNK) part 1 and 2 trials, associations between core and mismatch volume on pre-treatment CT-Perfusion with cerebral edema at 24-hours, and their interactions with reperfusion were tested. Core volume was associated with increased edema (p < 0.001) with no significant interaction with reperfusion (p = 0.82). In comparison, a significant interaction between reperfusion and mismatch volume (p = 0.03) was observed: Mismatch volume was associated with increased edema in the absence of reperfusion (p = 0.009) but not with reperfusion (p = 0.27). When mismatch volume was dichotomized at the median (102 ml), reperfusion was associated with reduced edema in patients with large mismatch volume (p < 0.001) but not with smaller mismatch volume (p = 0.35). The effect of reperfusion on edema may be variable and dependent on the physiological state of the cerebral tissue. In patients with small to moderate ischemic core volume, the benefit of reperfusion in reducing edema is related to penumbral salvage.
再灌注与水肿之间的关系尚不清楚,实验和临床数据得出的结果相互矛盾。我们研究了基线时可挽救和不可逆损伤组织的范围是否影响治疗性再灌注对脑水肿的影响。在 Tenecteplase 与 Alteplase 在前循环大血管闭塞性急性缺血性卒中血管内治疗前(EXTEND-IA TNK)试验 1 和 2 的 415 例患者的汇总分析中,测试了基线 CT 灌注中的核心梗死体积和不匹配体积与 24 小时脑水肿之间的相关性及其与再灌注的相互作用。核心梗死体积与水肿增加相关(p<0.001),但与再灌注无显著相互作用(p=0.82)。相比之下,再灌注与不匹配体积之间存在显著的相互作用(p=0.03):不匹配体积与无再灌注时脑水肿增加相关(p=0.009),但与再灌注无关(p=0.27)。当不匹配体积在中位数(102ml)处二分法时,再灌注与大不匹配体积患者的水肿减少相关(p<0.001),但与较小不匹配体积患者无关(p=0.35)。再灌注对水肿的影响可能是可变的,取决于脑组织的生理状态。在缺血核心体积较小至中等的患者中,再灌注减少水肿的益处与半暗带的挽救有关。